Clinical Trial Update: Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating DHA for treatment-refractory epilepsy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• DHA (Docosahexaenoic acid)

Snippet

Sponsor: The Canadian College of Naturopathic Medicine | Conditions: Epilepsy (Treatment Refractory) | Phase 2, Phase 3 | Status: TERMINATED